D3L-002 | Interleukin Related interleukin-related.com

Product Name :
D3L-002

Search keywords :
L002

drugId :
null

Target Vo:
Undisclosed

Target Vo Short Name :
Undisclosed

Moa_Name:
Undisclosed

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
D3 Bio (Wuxi) Co Ltd

Active Company_Name :
D3 Bio (Wuxi) Co Ltd

Active Indication_Name:
Solid tumours

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:
Preclinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Aquaporin 4 Antibody Autophagy
Rozanolixizumab medchemexpress
ChAT Antibody: ChAT Antibody is an unconjugated, approximately 82 kDa, rabbit-derived, anti-ChAT polyclonal antibody. ChAT Antibody can be used for: ELISA, IHC-P, IHC-F, Flow-Cyt, IF expriments in human, mouse, rat, and predicted: dog, pig background without labeling.

Author: Interleukin Related

Related Posts